Drugs / YB1-X7
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06889675 | Mar 2025 → Jan 2027 expected | neoplasm | Shanghai Salvectors Biotechnology LTD. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YB1-X7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06889675 ↗ |